Latest News about Teva
Recent news which mentions Teva
The bullish case for U.S. stocks is getting weaker
September 21, 2023
From MarketWatch
Stocks are trapped in a trading range. Something’s got to give.
September 14, 2023
From MarketWatch
3 No-Brainer Stocks to Buy With $20 Right Now
September 13, 2023
From Motley Fool
Why Can't You Find Adderall? Inside the Ongoing Shortage of ADHD Medication In US
September 12, 2023
Tickers
TEVA
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 11, 2023
From Benzinga
How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug
September 11, 2023
From Benzinga
Bristol Myers' Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug
September 07, 2023
From Benzinga
From Benzinga
Big Pharma Price-Fixing: Teva and Glenmark's $255M Settlement Shines Light on Industry Issues
August 22, 2023
Tickers
TEVA
From Benzinga
Zoom Video stock climbs after earnings, Activision Blizzard advances on Microsoft pact and other stocks on the move
August 22, 2023
From MarketWatch
FDA Greenlights Expanded Use Of Neurocrine Biosciences' Ingrezza: Analysts Weigh In Depression Warning
August 21, 2023
From Benzinga
Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged
August 10, 2023
From Benzinga
From Benzinga
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
August 02, 2023
From Benzinga
Tickers
TEVA
From Motley Fool
Humana, Waters, e.l.f. Beauty, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
August 02, 2023
From Benzinga
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 11, 2023
From Benzinga
From Benzinga
Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit
July 05, 2023
From Benzinga
After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology
June 28, 2023
From MarketWatch
From Benzinga
3 Bargain Stocks to Buy on the Dip
June 17, 2023
From Motley Fool
Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape
June 12, 2023
From Benzinga
From Benzinga
Is AbbVie or Amgen the Better Bargain Buy Right Now?
June 08, 2023
From Motley Fool
Tickers
TEVA
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.